Your browser doesn't support javascript.
loading
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang, Jie; Zhou, Caicun; Yao, Wenxiu; Wang, Qiming; Min, Xuhong; Chen, Gongyan; Xu, Xingxiang; Li, Xingya; Xu, Fei; Fang, Yong; Yang, Runxiang; Yu, Guohua; Gong, Youling; Zhao, Jun; Fan, Yun; Liu, Quan; Cao, Lejie; Yao, Yu; Liu, Yunpeng; Li, Xiaoling; Wu, Jingxun; He, Zhiyong; Lu, Kaihua; Jiang, Liyan; Hu, Chengping; Zhao, Wenhua; Zhang, Ben; Shi, Wei; Zhang, Xiaojing; Cheng, Ying.
Afiliação
  • Wang J; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Zhou C; Department of Medical Oncology, Shanghai Pulmonary Hospital, Shanghai, China.
  • Yao W; Department of Thoracic Oncology, Sichuan Cancer Hospital & Institute, Chengdu, China.
  • Wang Q; Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Min X; Department of Tumor Radiotherapy, Anhui Chest Hospital, Hefei, China.
  • Chen G; Department of Respiratory Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
  • Xu X; Department of Respiratory Medicine, Northern Jiangsu People's Hospital, Yangzhou, China.
  • Li X; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Xu F; Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China.
  • Yang R; Department of Internal Medicine, Yunnan Cancer Hospital, Kunming, China.
  • Yu G; Department of Medical Oncology, Weifang People's Hospital, Weifang, China.
  • Gong Y; Department of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China.
  • Zhao J; Department of Thoracic Oncology, Beijing Cancer Hospital, Beijing, China.
  • Fan Y; Department of Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Liu Q; Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Cao L; Department of Respiratory Medicine, Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Hospital, Hefei, China.
  • Yao Y; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Liu Y; Department of Oncology, The First Hospital of China Medical University, Shenyang, China.
  • Li X; Department of Thoracic Surgery, Liaoning Cancer Hospital & Institute, Shenyang, China.
  • Wu J; Department of Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • He Z; Department of Thoracic Medical Oncology, Fujian Medical University Cancer Hospital/Fujian Cancer Hospital, Fuzhou, China.
  • Lu K; Department of Oncology, Jiangsu Province Hospital, Nanjing, China.
  • Jiang L; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai, China.
  • Hu C; Department of Respiratory Medicine, Xiangya Hospital of Central South University, Changsha, China.
  • Zhao W; Department of Respiratory Oncology, Guangxi Medical University Affiliated Tumour Hospital, Nanning, China.
  • Zhang B; Jiangsu Hengrui Pharmaceuticals, Shanghai, China.
  • Shi W; Jiangsu Hengrui Pharmaceuticals, Shanghai, China.
  • Zhang X; Jiangsu Hengrui Pharmaceuticals, Shanghai, China.
  • Cheng Y; Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China. Electronic address: jl.cheng@163.com.
Lancet Oncol ; 23(6): 739-747, 2022 06.
Article em En | MEDLINE | ID: mdl-35576956

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China